WALLIN; Jeffrey

Patent Applications and Registrations

Patent applications and USPTO patent grants for WALLIN; Jeffrey.The latest application filed is for "methods for monitoring and treating cancer".

Company Profile

2.6.14

WALLIN; Jeffrey - Berkeley CA
Wallin; Jeffrey - South San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Monitoring And Treating Cancer App 20190038734 - WALLIN; Jeffrey ; et al.	2019-02-07
Methods For Monitoring And Treating Cancer App 20190032151 - Wallin; Jeffrey ; et al.	2019-01-31
Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use Grant 10,092,567 - Lin , et al. October 9, 2	2018-10-09
Mutant Selectivity And Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And Chemotherapeutic Agents For The Treatment Of Cancer App 20180280408 - Belvin; Marcia ; et al.	2018-10-04
Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use Grant 9,717,730 - Lin , et al. August 1, 2	2017-08-01
Combinations Of Akt Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use App 20170157124 - Lin; Kui ; et al.	2017-06-08
Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And A Cdk4/6 Inhibitor Compound For The Treatment Of Cancer App 20160279142 - Friedman; Lori ; et al.	2016-09-29
Combinations Of Akt Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use App 20160228440 - Lin; Kui ; et al.	2016-08-11
Mutant Selectivity And Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And Chemotherapeutic Agents For The Treatment Of Cancer App 20160045515 - Belvin; Marcia ; et al.	2016-02-18
Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer Grant 9,107,926 - Belvin , et al. August 18, 2	2015-08-18
Combinations Of Akt Inhibitor Compounds And Chemotheraeptuc Agents, And Methods Of Use App 20150064171 - Lin; Kui ; et al.	2015-03-05
Mutant Selectivity And Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And Chemotherapeutic Agents For The Treatment Of Cancer App 20140044706 - Belvin; Marcia ; et al.	2014-02-13
Combinations Of Phosphoinositide 3-kinase Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use App 20130345217 - Belvin; Marcia ; et al.	2013-12-26
Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use Grant 8,604,014 - Belvin , et al. December 10, 2	2013-12-10
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use Grant 8,247,397 - Belvin , et al. August 21, 2	2012-08-21
Combinations Of Phosphoinositide 3-kinase Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use App 20110223619 - Belvin; Marcia ; et al.	2011-09-15
Combinations Of A Pi3k Inhibitor And A Mek Inhibitor App 20110086837 - Belvin; Marcia ; et al.	2011-04-14
Combinations Of Phosphoinositide 3-kinase Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use App 20090098135 - Belvin; Marcia ; et al.	2009-04-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.